The US Food and Drug Administration (FDA) has voluntarily recalled 101 products made by Strauss Israel for potential contamination with Salmonella.
Elite chocolate, cakes, chewing gum, energy chocolate rice cakes, energy grain snacks, and wafers are among the products recalled by Strauss.
The Elite items were distributed to stores in California, Connecticut, Florida, New Jersey, and New York. Amazon, Fresh Direct, Passover.com, and other online stores have also carried kosher chocolates. The FDA's website has a complete list of the products that have been recalled.
The impacted chocolates and candies were created in a facility where Salmonella was discovered in both the liquid chocolate used in the goods and on production line equipment, according to the FDA. Customers who have purchased the products can return them for a full refund, and any merchant who carries them has been requested to remove them from the sale. In addition to the 101 products recalled in the US, the Canadian Food Inspection Agency (CIFA) has discovered 97 potentially contaminated products on the Canadian market.
According to the Strauss Group, they decided to act fully responsibly, not to take any risks, and remove all the factory products from the shelves.
The company also apologized to the Israeli public, customers, and retailers for the difficulty, while thanking them for their patience and vow9ng to get back to all inquiries.
The recall was initially limited to "more than a dozen types of chocolate and chocolate used as raw ingredients," but it was later expanded to include Elite-brand items. Two out of 270 chocolate goods tested positive for salmonella when Strauss tested samples from its plant. Since then, manufacturing at the company's plant has been temporarily halted.
According to the FDA, no illnesses have been linked to the recall in the United States. In Israel, 21 people who consumed the contaminated products developed symptoms that were compatible with salmonella, and the country's Health Ministry took samples from them.


Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends
Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data 



